International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-4 doi: 10.5281/zenodo.13359478
Original Research Article
A Study on Peripartum Hysterectomy in Tertiary Care Centre
Published
Aug. 22, 2024
Abstract

Peripartum hysterectomy is the rescue resort performed in modern obstetrics to arrest or prevent haemorrhage from intractable uterine atony or abnormal placentation. The aims and objectives of this study were to determine incidence, risk factors, indications and maternal outcome. An observational study conducted in KING GEORGE HOSPITAL, Visakhapatnam for a period of one year from September 2022 to August 2023.Total cases n=14 with 2.3 per 1000 deliveries. Risk factors observed were age group of 26-30 years, multiparous, vaginal mode of delivery in the current pregnancy and referred cases. Postpartum haemorrhage (PPH) was the most common indication. Out of 14 cases there were 4(28%) maternal deaths and Near miss were 9(72%). Good antenatal and intrapartum care and early referral would bring down cases of PPH as most of these cases are referred from peripheries and decreasing c section rates would help us to decrease incidence of peripartum hysterectomy.

Recommended Articles
Loading Image...
Volume-5, Issue-4
Citations
383 Views
349 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved